Free Republic

Last week, the World Tribune published an article revealing information that indicates the WHO likely knew ivermectin was effective for months, but blocked its use, all for Big Pharma. Dr. Andrew Hill, a senior visiting research fellow in pharmacology at Liverpool University, adviser to the Gates Foundation, and researcher for the WHO, was tasked with conducting an ivermectin trial for the WHO. Based on his preliminary findings, Hill testified enthusiastically about the use of ivermectin before the NIH COVID-19 Treatment Guidelines Panel on Jan. 6, 2021. But then he suddenly changed course and published a study dinging the drug’s efficacy...

As nations around the globe race to find different solutions to prevent the further spread of the dreaded COVID-19 virus, Israel gave interim approval for the sale of Canadian-based biotech company SaNOtize Research and Development’s Nitric Oxide Nasal Spray (NONS) branded as Enovid. SaNOtize developed and patented the platform technology that allows for the topical delivery of Nitric Oxide (the formula written as NO) for treating a variety of bacterial, fungal, and viral diseases. Utilizing the unique antimicrobial and immunomodulating properties of NO to treat both dermatologic and respiratory diseases, the production of this nose spray that claims to kill...

Enovid, a spray developed in Canada by SaNOtize and manufactured in Israel has been found to reduce viral loads in confirmed COVID-19 cases by 95% in 24 hours and 99% in 72 hours. The anti-viral nasal spray called Enovid that was developed in Canada and tested in the UK can reduce the viral loads in confirmed COVID-19 cases by 95% in 24 hours and 99% in 72 hours, a press release said on Sunday. *The Israeli-manufactured spray can be used up to five times a day after coming in contact with viruses, according to the release. It's suitable for children...

Nathan Jones, CEO of Xlear, said that he feels that his company is emerging from the COVID-19 pandemic in better shape and is prepared to help retailers in the post-COVID era. He talked with Drug Store News about the challenges ahead. Drug Store News: How has Xlear fared during the pandemic? Nathan Jones: Xlear as a company has fared fairly well. It is a respiratory pandemic and, within a month of it starting, we had physicians around the world tell people that using nasal sprays like ours, nasal sprays that contain antiviral agents, would be of benefit to them. There...

The leading U.S. manufacturer of xylitol-based products says the federal government is deliberately trying to conceal a nasal spray it developed that it says has been scientifically proven to be effective in treating and preventing COVID-19. The U.S. Department of Justice filed a lawsuit in federal court against Utah-based company Xlear on Oct. 28, saying it has deceptively advertised its nasal spray as a treatment and preventative of COVID-19. The lawsuit asks a federal court to permanently ban the company from promoting the nasal spray as a treatment for COVID-19 and also asks that monetary penalties be levied against it....

Imagine reducing your viral load of COVID and decreasing your chance of hospitalization 19-fold with a $15 solution. Well, the corporate media have gotten wind of it too, which is why they are now attacking the nasal irrigation concoctions, proving once again that they will slander every and any treatment that actually works – no matter how safe and effective.It is now becoming clear that not only do the vaccines not stop transmission, but they seem to have spawned even more transmission in the most vaccinated countries. Studies have shown that the vaccinated might also carry higher viral loads. Either...